Our goal is to accelerate our understanding of mutant DNAJB6 dysfunction in LGMDD1 and thus facilitate therapeutic target identification as well as to gain insight into the relationship between protein quality control and myopathy. The gene discussed is DNAJB6; the disease is myopathy.